- Home
- RPRX vs SNX Comparison
RPRX vs SNX Comparison
Compare RPRX & SNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- SNX
- Stock Information
- Founded
- RPRX 1996
- SNX 1980
- Country
- RPRX United States
- SNX United States
- Employees
- RPRX N/A
- SNX N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- SNX Retail: Computer Software & Peripheral Equipment
- Sector
- RPRX Health Care
- SNX Technology
- Exchange
- RPRX Nasdaq
- SNX Nasdaq
- Market Cap
- RPRX 13.9B
- SNX 11.2B
- IPO Year
- RPRX 2020
- SNX 2003
- Fundamental
- Price
- RPRX $35.59
- SNX $143.20
- Analyst Decision
- RPRX Strong Buy
- SNX Strong Buy
- Analyst Count
- RPRX 3
- SNX 9
- Target Price
- RPRX $48.33
- SNX $145.33
- AVG Volume (30 Days)
- RPRX 3.5M
- SNX 1.1M
- Earning Date
- RPRX 08-06-2025
- SNX 06-24-2025
- Dividend Yield
- RPRX 2.48%
- SNX 1.24%
- EPS Growth
- RPRX 37.60
- SNX 19.95
- EPS
- RPRX 2.45
- SNX 8.55
- Revenue
- RPRX $2,263,845,000.00
- SNX $60,007,297,000.00
- Revenue This Year
- RPRX $29.35
- SNX $4.63
- Revenue Next Year
- RPRX $7.58
- SNX $4.23
- P/E Ratio
- RPRX $14.47
- SNX $16.65
- Revenue Growth
- RPRX 1.13
- SNX 6.60
- 52 Week Low
- RPRX $24.05
- SNX $92.23
- 52 Week High
- RPRX $36.89
- SNX $145.10
- Technical
- Relative Strength Index (RSI)
- RPRX 52.61
- SNX 72.55
- Support Level
- RPRX $35.24
- SNX $140.06
- Resistance Level
- RPRX $36.89
- SNX $143.31
- Average True Range (ATR)
- RPRX 0.62
- SNX 2.48
- MACD
- RPRX -0.14
- SNX -0.17
- Stochastic Oscillator
- RPRX 22.16
- SNX 90.66
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About SNX TD SYNNEX Corporation
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.